Covid symptoms have largely stayed the same over the last few years: cough, congestion, fever, a sore throat, nausea, ...

A detailed examination of how patients respond to the drug at various times and doses provides greater context to a recent ...

Shares of the battered biotech Vir Biotechnology were up more than 70% on Wednesday, as the company reported its first ...

InflaRx N.V. IFRX shares gained 7.7% on Wednesday following the European Commission's (EC) approval of marketing ...

Patients with multiple myeloma (MM) can experience diminished immune responses during prolonged treatment; however, mRNA ...

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases.

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

The first severe human case of bird flu was recently reported in the U.S. Here are some ways the U.S. may be repeating the ...

Researchers have discovered that healthy skin — once thought to be a passive barrier — can actually produce antibodies that fight off infections. It’s hoped that the finding could one day lead to the ...

General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.